Skip to content
LGBTQIA, Medical Health Aged Care

Australia urged to accelerate action to end viral hepatitis

Hepatitis Australia 2 mins read

Friday, 5 July 2024

Australia has been urged to accelerate action to eliminate viral hepatitis, with Health Minister Mark Butler MP addressing a renewed push to curb the epidemics.

He spoke alongside Senators Louise Pratt and Dean Smith, Co-Chairs of Parliamentary Friends for ending HIV, STIs and Other Blood Borne Viruses, at Thursday’s federal parliamentary World Hepatitis Day event.

Minister Butler highlighted the need for further action on prevention. 

“In partnership with affected communities, national peak bodies, peer and community organisations and the clinical multidisciplinary workforce, we are examining how to reduce the transmission of hepatitis C in the prison system,” he said.  

“We are determined to explore new ways in which we can make a difference in those settings.” 

Minister Butler also said the government was committed to funding hepatitis B elimination, with $7.8 million for a public awareness campaign and workforce training. 

Hepatitis Australia Vice President Frank Carlus said ongoing investment was crucial to meet Australia’s goals of eliminating viral hepatitis by 2030. 

“Australia has been a leader in global efforts to eliminate blood-borne viruses. We have an unprecedented opportunity to end hepatitis B and C by 2030. Our task is to seize this opportunity and accelerate efforts to end these epidemics,” he said. 

“We’ve worked closely with the Commonwealth and state and territory governments on new national strategies to achieve this goal. We look forward to the release of these strategies for elimination in coming months.

“Eliminating viral hepatitis will save thousands of lives. Any delay simply prolongs the period in which people are needlessly infected and need diagnosis and treatment to stay well. 

“Accelerating our efforts now will end this epidemic earlier.”

Nearly 300,000 people in Australia live with hepatitis B or C, increasing their risk of liver disease and liver cancer.

Chronic hepatitis B can be managed effectively with antiviral treatment, but three in four people with the condition do not receive regular care. About one in five people with hepatitis C, which is both curable and preventable, do not know they have it. 

The National Aboriginal Community Controlled Health Organisation, Scarlet Alliance, Australian Injecting and Illicit Drug Users League, Hepatitis B Voices Australia, and State and Territory Community Hepatitis Organisations attended on behalf of communities disproportionately affected by viral hepatitis. 

Sector partners including the Burnet Institute, Doherty Institute, and ASHM Health attended, representing researchers and clinicians on the frontline of efforts to eliminate the disease.

Nicoletta Estella, who has lived experience of hepatitis C and is a Peer Community Development Worker, called for a stronger focus on community responses. 

"A national response to BBVs  must include meaningful partnerships with people affected by hepatitis and continue a historical evidence based approach. Community-led harm reduction programs have saved countless lives," she said.

For more information, contact Georgie Moore 0477 779 928

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.